Qure co-founders Prashant Warier and Pooja Rao embarked on this journey in 2016, combining their expertise in deep learning, clinical knowledge, and scientific insights.
Back
Qure.ai's prime offering is an automated chest X-ray interpretation technology that delivers precise readings in less than a minute.
It can identify 28 different markers and detect tuberculosis, distinguish between typical and unconventional X-rays, and quantify the extent of lung infection. This innovative solution is now pivotal in the battle against the COVID-19 pandemic.
Another significant product by Qure.ai pertains to head CT scan interpretation. This AI algorithm, trained on thousands of X-rays and CT scans, pinpoints the brain's unconventionalities and gauges their severity.
The impact of AI in healthcare extends beyond Qure.ai, ranging from physical robots in hospitals to surgical aids, patient care, administrative tasks, and even drug discovery and vaccine development. With the AI health market projected to reach $6.6 billion by 2021, Qure.ai is riding this transformative technology's wave, helping redefine healthcare for a brighter future.
